Newsletter registration

Используя наш сайт, Вы соглашаетесь с тем, что в целях обеспечения оптимального сервиса на Вашем компьютере будут сохраняться файлы Cookie и будет использоваться служба Google Analytics. Более подробную информацию об этом Вы найдетездесь.
Австрия
Блестящие перспективы для роста Вашей прибыли

Test can spare breast cancer patients the need for chemotherapy

The approximately 5,200 women diagnosed with breast cancer each year in Austria are divided into subgroups. Hormone-receptor positive tumors are the most common type of breast cancer. Their growth is supported by the female sexual hormone estrogen. The standard therapy for this kind of tumor is the so-called anti-hormonal therapy.

Up until now, further treatment was determined on the basis of clinical parameters such as the size of the tumor, the occurrence of lymph nodes, age and hormone sensitivity.  In order to reduce the risk of having a relapse, doctors often decide to carry out chemotherapy over a period of months, with all the related side effects such a tiredness, loss of hair, nausea and other symptoms.

In this regard, this type of therapy would not be necessary in some cases, in light of the fact that some patients would anyway have had a low relapse risk. This risk is now identified by the Prosigna(R) test. These patients have a risk of less than ten percent over the next ten years, which applies to about one third of all breast cancer patients. 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter

Отзывы

Мероприятия

Познакомьтесь с нами в рамках мероприятий, семинаров и выставок по всему миру

Austria Map

Find the perfect location for your company

Австрия занимает ключевую позицию для бизнеса между Востоком и Западом. Мы высоко ценим превосходную инфраструктуру, в особенной мере отличное воздушное сообщение, высококвалифицированные трудовые кадры, а также первоклассное качество жизни в Вене.

ЛУКОЙЛ

Lukoil Logo
Все отзывы

Новости Австрии, как площадки для бизнеса

September 12-14, 2018: 1MillionStartups Global Conference in Vienna

The Viennese startup hub weXelerate is hosting the very first 1MillionStartups Global Conference from September 12-14, 2018.

Testing the potential early detection of ovarian cancer

About 75 percent of the cases of extremely aggressive ovarian cancer (ovarian carcinoma) originally arise in the fallopian tube. Currently there are no possibilities to detect this at an early stage. A new catheter system developed by Viennese scientists could represent a new possibility to deal with this.

Все новости